Celecoxib can induce cell death independently of cyclooxygenase-2, p53, Mdm2, c-Abl and reactive oxygen species

Sue Haupt1, Jackie Kleinstern, Ygal Haupt

  • 1Department of Hematology, Hadassah University Hospital, Jerusalem, Israel. haupt@vms.huji.ac.il

Anti-Cancer Drugs
|August 19, 2006
PubMed

Insights

Celecoxib resistance in cells lacking cyclooxygenase-2 (COX-2) was observed. Despite inducing reactive oxygen species (ROS), celecoxib

Area of Science:

  • Pharmacology
  • Cell Biology
  • Biochemistry

Background:

  • Cyclooxygenase-2 (COX-2) is a target for celecoxib.
  • Some cell lines exhibit resistance to celecoxib at normal plasma concentrations.

Purpose of the Study:

  • To investigate the mechanisms of celecoxib resistance and cell death.
  • To explore the role of p53, Hdm2, and reactive oxygen species (ROS) in celecoxib's effects.

Main Methods:

  • Exposure of cell lines to varying concentrations of celecoxib.
  • Assessment of cell growth inhibition and death.
  • Analysis of p53 and Hdm2 protein levels.
  • Measurement of reactive oxygen species (ROS) generation.
  • In vitro xanthine oxidase activity assay.

Main Results:

  • Cell lines lacking functional COX-2 were resistant to celecoxib.
  • Celecoxib inhibited cell growth at 80 µmol/l and induced death at 120 µmol/l.
  • Cell death and growth inhibition were independent of p53 and Hdm2.
  • Celecoxib induced ROS generation within 4 hours, independent of p53 and c-Abl.
  • In vitro, celecoxib enhanced superoxide radical production by xanthine oxidase.
  • Antioxidants failed to protect cells from celecoxib-induced death.

Conclusions:

  • Celecoxib resistance is linked to the absence of functional COX-2.
  • Celecoxib induces cell death through a mechanism independent of ROS, despite ROS generation.
  • p53 and Hdm2 are not essential mediators of celecoxib-induced cell death in these models.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.